Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Cancers|June 2, 2021
Cell-Penetrating CEBPB and CEBPD Leucine Zipper Decoys as Broadly Acting Anti-Cancer AgentsQing Zhou, Xiotian Sun, Nicolas Pasquier, et al.
Oncotarget|October 17, 2015
TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners in vitro and in vivoGeorg Karpel-Massler, Maïmouna Bâ, Chang Shu, et al.
Oncotarget|May 14, 2016
Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivoGeorg Karpel-Massler, Doruntina Ramani, Chang Shu, et al.
JCI Insight|September 25, 2025
CDK12 regulates cellular metabolism to promote glioblastoma growthJeong-Yeon Mun, Chang Shu, Qiuqiang Gao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 19, 2010
Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow upTimo Gaiser, Heinz Kutzner, Gabriele Palmedo, et al.
Oncotarget|February 13, 2016
Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivoGeorg Karpel-Massler, Matei A Banu, Chang Shu, et al.
Molecular and Cellular Therapies|June 10, 2015
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapyMike-Andrew Westhoff, Georg Karpel-Massler, Oliver Brühl, et al.
Cells|July 16, 2020
Inhibition of HDAC1/2 Along with TRAP1 Causes Synthetic Lethality in Glioblastoma Model SystemsTrang T T Nguyen, Yiru Zhang, Enyuan Shang, et al.
Research Square|October 27, 2023
MGMT promoter methylation in 1p19q-intact gliomasConnor Kinslow, Markus D Siegelin, Fabio M Iwamoto, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in GlioblastomaMarc-Eric Halatsch, Annika Dwucet, Carl Julius Schmidt, et al.
Pageof 9